Alliance for cervical cancer prevention: Setting the record straight [5]

American Journal of Public Health

Volumn 97, Issue 2, 2007, Pages 200-201

  Sherris, Jacqueline ^a   Wright Jr , Thomas C ^b   Denny, Lynette ^c   Sankaranarayanan, Rengaswamy ^d   Pollack, Amy E ^e   Sanghvi, Harshad ^f   Sellors, John W ^a  

^a PATH   (United States)

^b Columbia University ^*  (United States)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^e Department of Medicine   (United States)

^f JHPIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

CANCER MORTALITY; CANCER PREVENTION; CANCER SCREENING; DEVELOPING COUNTRY; DNA DETERMINATION; HEALTH CARE ACCESS; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; LETTER; MEDICAL ETHICS; PAPANICOLAOU TEST; SCREENING TEST; UTERINE CERVIX CANCER; WART VIRUS; WOMEN'S HEALTH; FEMALE; HEALTH SERVICE; MASS SCREENING; METHODOLOGY; NOTE; ORGANIZATION AND MANAGEMENT; PATHOLOGY; UTERINE CERVIX TUMOR; VAGINA SMEAR;

DEVELOPING COUNTRIES; FEMALE; HEALTH POLICY; HUMANS; MASS SCREENING; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; WOMEN'S HEALTH SERVICES;

EID: 33846915168     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.2006.104273     Document Type: Letter

References (11)

1. Suba EJ, Murphy SK, Donnelly AD, Furia LM, Huynh ML, Raab SS. Systems analysis of real-world obstacles to successful cervical cancer prevention in developing countries. Am J Public Health. 2006;96:480-487.
2. Suba EJ, Donnelly AD, Furia LM, Huynh ML, Raab SS. Coming to terms with Vietnam: the Viet/American cervical cancer prevention project. Diagn Cytopathol. 2005;33(5):344-351.
3. Wright TC, Blumenthal P, Bradley J, et al. ACCP letter to the editor. Diagn Cytopathol. In press.
4. Sankaranarayanan R, Nene BM, Dinshaw KA, et al. A cluster randomized controlled trial of visual, cytology and human papillomavirus screening for cancer of the cervix in rural India. Int J Cancer. 2005;116:617-623.
5. Goldie SJ, Gamkin L, Goldhaber-Fiebert JD, et al. Cost-effectiveness of cervical-cancer screening in five developing countries. N Engl J Med. 2005;353:2158-2168.
6. Royal Thai College of Obstetricians and Gynecologists/JHPIEGO Corporation, Cervical Cancer Prevention Group. Safety, acceptability, and feasibility of a single-visit approach to cervical cancer prevention in rural Thailand: a demonstration project [published correction appears in Lancet. 2003;361(9373):1994]. Lancet. 2003;361(9360):814-820.
7. Denny L, Kuhn L, De Souza M, Pollack AE, Dupree W, Wright TC Jr. Screen-and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial. JAMA. 2005;294:2173-2181.
8. Sankaranarayanan R, Gaffikin L, Jacob M, Sellors J, Robles S. A critical assessment of screening methods for cervical neoplasia. Int J Gynaecol Obstet. 2005;89(suppl 2):S4-S12.
9. Jacob M, Broekhuizen FF, Castro W, Sellors J. Experience using cryotherapy for treatment of cervical precancerous lesions in low-resource settings. Int J Gynaecol Obstet. 2005;89(suppl 2):S13-S20.
10. Planning and Implementing Cervical Cancer Prevention and Control Programs: A Manual for Managers. Seattle, Wash: Alliance for Cervical Cancer Prevention; 2004.
11. Robles SC, Periago MR. Guanacaste, Costa Rica: a landmark for cervical cancer prevention [published correction appears in Rev Panam Salud Publico. 2006;19(3):162]. Rev Panam Salud Publica. 2004;15(2):73-74.